Alessandra Daigneault is General Counsel & Secretary of NRX Pharmaceuticals, Inc.. Currently has a direct ownership of 31,584 shares of NRXP, which is worth approximately $52,113. The most recent transaction as insider was on Sep 02, 2021, when has been sold 31,584 shares (Common Stock) at a price of $3.07 per share, resulting in proceeds of $96,963. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.6K
0% 3M change
0% 12M change
Total Value Held $52,113

Alessandra Daigneault Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 02 2021
BUY
Exercise of conversion of derivative security
$96,963 $3.07 p/Share
31,584 Added 50.0%
31,584 Common Stock
Aug 23 2021
SELL
Open market or private sale
$442,004 $13.11 p/Share
33,715 Reduced 100.0%
0 Common Stock
Aug 19 2021
BUY
Exercise of conversion of derivative security
$84,103 $3.07 p/Share
27,395 Added 44.83%
33,715 Common Stock
May 24 2021
BUY
Grant, award, or other acquisition
-
6,320 Added 50.0%
6,320 Common Stock
AD

Alessandra Daigneault

General Counsel & Secretary
Wilmington, DE

Track Institutional and Insider Activities on NRXP

Follow NRX Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRXP shares.

Notify only if

Insider Trading

Get notified when an Nrx Pharmaceuticals, Inc. insider buys or sells NRXP shares.

Notify only if

News

Receive news related to NRX Pharmaceuticals, Inc.

Track Activities on NRXP